| In search of preclinical robustness. | |
| | |
MedLine Citation:
|
PMID: 23023666 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Systematic engagement of statisticians in preclinical research could help address the weaknesses that are undermining the likelihood of subsequent success in drug discovery and development. |
| | |
Authors:
|
Ian S Peers; Peter R Ceuppens; Chris Harbron |
Related Documents
:
|
23505516 - Mapping systematic reviews on atopic eczema-an essential resource for dermatology profe... 19217386 - Outcome of a workshop on applications of protein models in biomedical research. 23009586 - Nanomaterials in the field of design ergonomics: present status. 22359736 - Spatio-temporal dynamics of a fish spawning aggregation and its fishery in the gulf of ... 10635506 - Fraud, misconduct or normal science in medical research--an empirical study of demarcat... 18617496 - Patients' refusal to consent to storage and use of samples in swedish biobanks: cross s... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Nature reviews. Drug discovery Volume: 11 ISSN: 1474-1784 ISO Abbreviation: Nat Rev Drug Discov Publication Date: 2012 Oct |
Date Detail:
|
Created Date: 2012-10-01 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101124171 Medline TA: Nat Rev Drug Discov Country: England |
Other Details:
|
Languages: eng Pagination: 733-4 Citation Subset: IM |
Affiliation:
|
AstraZeneca 13F41 Mereside, Alderley Park, Macclesfield SK10 4TG, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Genomics of sex determination in Drosophila.
Next Document: Targeting IL-17 and T(H)17 cells in chronic inflammation.